TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Diet and Exercise After Pancreatic Cancer
- Status
- COMPLETED
- Phase
- NA
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS)
- Status
- UNKNOWN
- Phase
- NA
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Prevention of Chyle-leak After Major Pancreatic Surgery
- Status
- RECRUITING
- Phase
- NA
A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
- Status
- TERMINATED
- Phase
- N/A
GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis
- Status
- COMPLETED
- Phase
- NA
High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue
- Status
- UNKNOWN
- Phase
- N/A
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism
- Status
- UNKNOWN
- Phase
- PHASE2